14572 Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton—DC/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Michael B. Small, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8127, Bethesda, MD 

20892–8328. 301–402–0996. 

smallm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI 

Clinical Studies. 

Date: June 15–17, 2009. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Majed M. Hamawy, PhD, 

MBA, Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramual Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8135, Bethesda, MD 20852. 301–594– 

5659. mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cancer 

Prevention, Control and Population Sciences. 

Date: June 16–17, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton—Rockville, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Wlodek Lopaczynski, MD, 

PhD, Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8131, 

Bethesda, MD 20892. 301–594–1402. 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, SPORE 

Review. 

Date: June 16–18, 2009. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Shamala K. Srinivas, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 8123, Bethesda, 

MD 20892, 301–594–1224, ss537t@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Application Use of Transformative Emerging 

Technologies in Cancer Research. 

Date: June 22–23, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Viatcheslav A. 

Soldatenkov, MD, PhD, Scientific Review 

Officer, Special Review And Logistics 

Branch, Division of Extramural Activities, 

National Cancer Institute, 6116 Executive 

Blvd., Room 8050a, Bethesda, MD 20892– 

8329, 301–451–4758, 

soldatenkovv@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 24, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–7206 Filed 3–30–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meeting will he closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Loan 

Repayment. 

Date: March 30, 2009. 

Time: 9 a.m. to 5p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852 

(Virtual Meeting). 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Mouse 

Gene Development Initiative. 

Date: May 6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel, 8120 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Minna Liang, PhD, 

Scientific Review Officer, Training and 

Special Projects Review Branch, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, 6101 Executive Blvd., 

Room 220, MSC 8401, Bethesda, MD 20852, 

301–435–1432, liangm@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Brain 

Imaging Studies of Negative Reinforcement 

in Humans. 

Date: May 29, 2009. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Kristen V Huntley, PhD, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, 301–435–1433, 

huntleyk@mail.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group; Health 

Services Research Subcommittee. 

Date: June 9–10, 2009, 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Madison Lowes Hotel, 1177 

Fifteenth Street, NW., Washington, DC 

20005. 

Contact Person: Meenaxi Hiremath, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6101 Executive Blvd., Suite 220, MSC 

8401, Bethesda, MD 20892, 301–402–7964, 

mh392g@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: March 20, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–6781 Filed 3–30–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meeting will be closed to the 

public in accordance with the 


tjames on PRODPC61 with NOTICES